Medical Devices and IVDs
Establish, audit or remediate your quality systems with guidance from our team of former regulators. Our experts help you prepare for market, mitigate risk and achieve sustainable compliance with country-specific regulations and international standards.
How Can We Help?
We Offer Custom Training
EU MDR: What Does It Mean for the Medical Device Industry?
Kim Trautman looks at the key changes occurring with the EU MDR, including additional post-market surveillance. She explores how companies can prepare for the May 2021 deadline, including ways in which NSF can offer support.
Webinar: A Regulatory Q&A With IVD Expert Robyn Meurant
Robyn Meurant, NSF’s in vitro diagnostic (IVD) expert, answers your questions on IVD Regulation (EU) 2017/746 in the lead up to the May 26, 2022 deadline.
NSF Health Sciences Journal: Time to Rethink - Issue 47, 2020
News and Events
NSF Health Sciences Podcasts – Access Expert Content On-the-Go
October 22, 2020
Access a wealth of free podcasts and webinar recordings from our pharma and medical devices experts to help you make better business decisions and stay up to date with the latest industry trends.
NSF Now Offering Live Instructor-Led Virtual Pharmaceutical and Medical Devices Training
May 19, 2020
To complement its face-to-face offering, NSF now offers traditional classroom courses as virtual instructor-led training to support your professional development. Courses are delivered via a combination of live instructor-led virtual classrooms and self-paced online learning. NSF’s coaches are on hand to guide participants through the interactive sessions which also include pre- and post-course activities.
NSF International’s Health Sciences Team Joins Fight to Save Lives With More Ventilators
April 23, 2020
NSF International’s health sciences team is hands-on in the rapid ventilator manufacturing specification issued by the United Kingdom (UK) government. The UK National Health Service needs thousands more ventilators to help save lives as the country’s COVID-19 pandemic approaches its expected peak and ventilator capacity becomes a challenge.
Amarex, an NSF International Company, Executes Five Rush COVID-19 Related Submissions to the FDA
April 2, 2020